搜索优化
Rewards
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
7 天
谁将迭代奥希替尼?
第三代EGFR TKI已经向大家展示这类药市场规模有多么可观:奥希替尼2015年获批上市,2023年总销售额已经达到57.99亿美元。在中国,奥希替尼、阿美替尼和伏美替尼三分天下之势已经成型,第三代EGFR ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
今日热点
Columbus’ DNA study
How to help Milton victims
US condemns China drills
'Terrifier 3' tops box office
Historic park closes
Free gas for FL residents
SpaceX’s mega rocket feat
Man arrested near rally
NFL fines 49ers $100K
Sued by former assistant
‘Dark Shadows’ star dies
Dems shut down AZ office
Toxic mushrooms poison 11
Meal service safety concern
Sets marathon world record
1st three-time HOF inductee
Turtle smuggling guilty plea
Shooting near TSU
Hunter's Moon this week
Vows to hire more agents
Releases medical report
Soldier sentenced to 14 yrs
Wins Xfinity Series race
Says systems were breached
Biden surveys storm damage
Whooping cough cases rise
Tour guide killed in mine
Under federal investigation
Anti-missile system for ISR
$1.49M for Iron Throne
反馈